Actionable news
All posts from Actionable news
Actionable news in RGLS: Regulus Therapeutics Inc.,

Regulus Therapeutics, Inc's (RGLS) CEO Paul Grint on Q3 2015 Results - Earnings Call Transcript


Good afternoon, ladies and gentlemen, and welcome to the Regulus Therapeutics Third Quarter 2015 Financial Results Conference Call. My name is Perea, and I will be your coordinator for today.

I would now like to turn the call over to the company. Please proceed.

Amy Conrad - Senior Director, Investor Relations & Corporate Communications

Thank you and good afternoon, everyone. This is Amy Conrad, Senior Director, Investor Relations and Corporate Communications and I'd like to welcome you to our financial results call for the quarter ended September 30, 2015.

With me today from Regulus are Paul Grint, M.D., President and Chief Executive Officer; David Szekeres, Chief Business Officer and General Counsel; and Mike Huang, M.D. who recently joined us in late August as Vice President of Clinical Development. So, welcome to Mike.

Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Regulus' future expectations, plans, prospects, corporate strategy and performance, which constitutes forward-looking statements for the purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from...